# FDA 483 - Houston Fertility Center - December 30, 2025

Source: https://www.keypedia.com/records/483/houston-fertility-center/2e8d7048-3562-4d6b-b9f2-4c703c870c6f

> FDA 483 for Houston Fertility Center on December 30, 2025. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Houston Fertility Center
- Inspection Date: 2025-12-30
- Product Type: other
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: This FDA Form 483 report details significant deficiencies at Houston Fertility Center related to the processing and handling of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). The firm failed to properly screen donors for communicable diseases, maintain adequate records, and ensure appropriate labeling for HCT/Ps, including those from ineligible donors. These issues indicate a lack of robust procedures and adherence to regulations concerning donor eligibility and product safety.

## Related Officers

- [Elyshia Q. Danaher](https://www.keypedia.com/people/elyshia-q-danaher/73046c15-abb1-431e-8a76-59c7e8c1604a)

Company: https://www.keypedia.com/companies/houston-fertility-center/1879937e-2898-4ccf-80d2-3c6111e6f50e

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab